Assessment of the Inactivation Potential of Desethylamiodarone on Human CYP1A1

Publisher： Bentham Science Publishers

E-ISSN： 1874-0758|4|1|9-14

ISSN： 1872-3128

Source： Drug Metabolism Letters, Vol.4, Iss.1, 2010-01, pp. : 9-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

THE HUMAN CYP3A SUBFAMILY: PRACTICAL CONSIDERATIONS1 *

By WRIGHTON STEVEN   SCHUETZ ERIN   THUMMEL KENNETH   SHEN DANNY   KORZEKWA KENNETH   WATKINS PAUL  

Drug Metabolism Reviews, Vol. 32, Iss. 3-4, 2000-10 ,pp. : 339-361

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Potential of the Inhibition of the Retinoic Acid Hydroxylases CYP26A1 and CYP26B1 by Xenobiotics

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 12, 2013-06 ,pp. : 1402-1428

Bentham Science Publishers

Access to resources Recommend Favorite

Extra-Hepatic Isozymes from the CYP1 and CYP2 Families as Potential Chemotherapeutic Targets

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 12, 2013-06 ,pp. : 1441-1453

Bentham Science Publishers

Access to resources Recommend Favorite

Caffeine Induces CYP1A2 Expression in Rat Hepatocytes but not in Human Hepatocytes

By  

Drug Metabolism Letters, Vol. 6, Iss. 2, 2012-01 ,pp. : 116-119

Bentham Science Publishers

Access to resources Recommend Favorite

Induction of CYP2B6 and CYP3A4 Expression by 1-Aminobenzotriazole (ABT) in Human Hepatocytes

By  

Drug Metabolism Letters, Vol. 4, Iss. 3, 2010-08 ,pp. : 129-133

Bentham Science Publishers

Access to resources Recommend Favorite